Stem Cell Research (Aug 2019)

An induced pluripotent stem cell line (TRNDi010-C) from a patient carrying a homozygous p.R401X mutation in the NGLY1 gene

  • Shu Yang,
  • Yu-Shan Cheng,
  • Rong Li,
  • Manisha Pradhan,
  • Junjie Hong,
  • Jeanette Beers,
  • Jizhong Zou,
  • Chengyu Liu,
  • Matt Might,
  • Steven Rodems,
  • Wei Zheng

Journal volume & issue
Vol. 39

Abstract

Read online

NGLY1 deficiency is a rare inherited disorder caused by mutations in the NGLY1 gene encoding N-glycanase 1 that is a hydrolase for N-linked glycosylated proteins. An induced pluripotent stem cell (iPSC) line was generated from the dermal fibroblasts of a 16-year-old patient with homozygous mutation of p.R401X (c.1201 A>T) in the NGLY1 gene. Our iPSC model offers a useful resource to study the disease pathophysiology and to develop therapeutics for treatment of NGLY1 patients.